tiprankstipranks
Trending News
More News >
Healthstream (HSTM)
NASDAQ:HSTM

HealthStream (HSTM) AI Stock Analysis

Compare
123 Followers

Top Page

HSTM

HealthStream

(NASDAQ:HSTM)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
$27.00
▲(22.50% Upside)
HealthStream's overall stock score reflects strong financial performance and positive earnings call highlights, tempered by a bearish technical outlook and high valuation. The company's strategic acquisitions and strong cash position support future growth prospects.
Positive Factors
Strategic Acquisitions
The acquisition of MissionCare Collective enhances HealthStream’s workforce ecosystem, offering comprehensive career tools and professional development opportunities, thus creating synergies and adding value for stakeholders in the healthcare industry.
Strong Cash Position
A robust cash position provides HealthStream with the financial flexibility to invest in growth opportunities, manage debt, and return value to shareholders, supporting long-term business stability.
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business strategies, enhancing HealthStream's competitive position in the healthcare information services industry.
Negative Factors
Declining Legacy Product Revenues
The decline in legacy product revenues suggests potential challenges in maintaining older product lines, which may impact overall revenue growth and necessitate increased focus on innovation and new product development.
Gross Margin Decline
A decline in gross margin can indicate rising costs or pricing pressures, potentially affecting profitability if not addressed through cost management or pricing strategies.
Professional Service Revenues Decline
A decrease in professional service revenues may reflect reduced demand or competitive pressures, which could impact future growth if not countered by strategic adjustments or service enhancements.

HealthStream (HSTM) vs. SPDR S&P 500 ETF (SPY)

HealthStream Business Overview & Revenue Model

Company DescriptionHealthStream, Inc. provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the range of its clinical development, talent management, training, education, certification, scheduling, competency assessment, performance appraisal, and other needs, as well as implementation and account management services. It also provides applications for learning, performance appraisal, competency management, disclosure management, clinical assessment and development, simulation-based education, quality management, and industry training. In addition, the company offers VerityStream that delivers enterprise-class solutions to transform the healthcare provider experience for ambulatory surgery centers, urgent care facilities, clinics, medical groups, and other healthcare organizations; EchoCredentialing and MSOW platforms that manage medical staff credentialing, enrollment, and privileging processes for hospitals; and EchoOneApp, a provider enrollment platform for medical groups. Further, it provides CredentialMyDoc, a credentialing and enrollment SaaS solution for medical groups and surgery centers; CredentialStream, a SaaS-based provider credentialing, privileging, and enrollment solution; and NurseGrid Mobile for nurse managers. The company offers its solutions in healthcare industry companies that include private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through direct sales teams. HealthStream, Inc. was incorporated in 1990 and is headquartered in Nashville, Tennessee.
How the Company Makes MoneyHealthStream generates revenue primarily through subscription-based services and software licensing fees. The company offers its products on a recurring subscription model, allowing healthcare organizations to access its learning and performance management platforms for a monthly or annual fee. Key revenue streams include fees from its online learning courses, performance appraisal systems, and patient experience measurement tools. Additionally, HealthStream may engage in partnerships with healthcare institutions and organizations to provide customized training and consulting services, further contributing to its earnings. The company also benefits from the growing demand for healthcare workforce solutions driven by regulatory changes and the increasing need for skilled healthcare professionals.

HealthStream Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Chart Insights
Data provided by:The Fly

HealthStream Earnings Call Summary

Earnings Call Date:Nov 03, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 23, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mix of positive and negative aspects. While HealthStream achieved record revenues and showed strong growth in core solutions, it faced challenges with declining legacy product revenues, a drop in gross margin, and decreased professional service revenues. The acquisition of Virsys12 and a strong cash position are positive signs for future growth.
Q3-2025 Updates
Positive Updates
Record Quarterly Revenues
HealthStream achieved record quarterly revenues of $76.5 million, up 4.6% from the third quarter of last year.
Operating and Net Income Growth
Operating income increased by 16.5%, while net income rose by 6.3% compared to the same quarter last year.
Strong Performance in Core Solutions
CredentialStream grew by 23%, ShiftWizard by 29%, and Competency Suite by 18%.
Acquisition of Virsys12
HealthStream acquired Virsys12 to strengthen and expand its entry into the payer and health plan space.
Large Cash Balance
The company reported a strong cash balance of $92.6 million at the end of the third quarter.
Improved Cash Flow
Cash flows from operations were $50.1 million year-to-date, up from $46.5 million last year, an increase of 7.8%.
Negative Updates
Decline in Legacy Product Revenues
Revenues from legacy credentialing and scheduling applications declined by $1.7 million compared to last year.
Gross Margin Decline
Gross margin decreased to 65.3% from 66.5% in the prior year quarter, impacted by increased cloud hosting and software licensing costs.
Professional Service Revenues Decline
Professional service revenues were down $0.6 million or 18.6%.
Company Guidance
During HealthStream's third quarter 2025 earnings call, the company reported record quarterly revenues of $76.5 million, marking a 4.6% increase from the same quarter last year. Operating income rose by 16.5% to $7.6 million, while net income increased by 6.3% to $6.1 million. The company's adjusted EBITDA also reached a new high at $19.1 million, up 7.9%. HealthStream updated its full-year 2025 financial guidance, maintaining the same midpoints but narrowing the range for each financial metric. The guidance predicts consolidated revenues between $299.5 million and $301.5 million, net income ranging from $20.3 million to $21.5 million, and adjusted EBITDA between $69.5 million and $71.5 million. The recent acquisition of Virsys12 is expected to contribute approximately $900,000 to fourth-quarter revenue, offsetting a $3 million anticipated decline in legacy products. The company emphasizes its strong cash balance of $92.6 million and continues to focus on expanding its career networks and enterprise application suites within the healthcare workforce sector.

HealthStream Financial Statement Overview

Summary
HealthStream exhibits a strong financial performance across all verticals. The income statement shows consistent revenue growth and profitability, while the balance sheet reflects a low-risk financial structure with minimal leverage. The cash flow statement indicates robust cash generation and growth. Overall, the company is well-positioned financially, with strengths in revenue growth, profitability, and financial stability.
Income Statement
78
Positive
HealthStream's income statement shows a solid performance with a consistent revenue growth rate of 1.145% in the TTM period. The gross profit margin remains strong at 65.64%, indicating efficient cost management. The net profit margin of 6.89% is stable, reflecting healthy profitability. EBIT and EBITDA margins are also robust, suggesting effective operational management. Overall, the company demonstrates strong revenue growth and profitability.
Balance Sheet
82
Very Positive
The balance sheet of HealthStream is strong, with a low debt-to-equity ratio of 0.045, indicating low financial leverage and risk. The return on equity is modest at 5.70%, showing decent profitability relative to shareholder equity. The equity ratio of 69.85% highlights a solid capital structure with a significant portion of assets financed by equity. The company maintains a stable and low-risk financial position.
Cash Flow
75
Positive
HealthStream's cash flow statement reflects a positive trajectory with a free cash flow growth rate of 12.47% in the TTM period. The operating cash flow to net income ratio is 0.54, indicating strong cash generation relative to net income. The free cash flow to net income ratio of 0.73 further supports the company's ability to generate cash. Overall, the cash flow position is healthy, with good cash generation and growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue298.59M291.65M279.06M266.83M256.71M244.83M
Gross Profit195.12M193.71M184.04M175.68M165.68M155.49M
EBITDA66.11M62.53M57.09M50.39M44.87M46.01M
Net Income20.70M20.01M15.21M12.09M5.84M14.09M
Balance Sheet
Total Assets499.93M510.77M499.94M497.74M486.75M500.31M
Cash, Cash Equivalents and Short-Term Investments92.59M97.22M71.13M53.91M51.95M46.49M
Total Debt15.29M20.17M20.25M23.32M29.11M31.87M
Total Liabilities150.74M151.41M159.19M163.68M147.73M166.25M
Stockholders Equity349.19M359.36M340.75M334.06M339.02M334.06M
Cash Flow
Free Cash Flow57.60M29.52M61.77M49.42M38.97M33.89M
Operating Cash Flow61.29M57.66M63.97M51.19M42.38M35.87M
Investing Cash Flow-35.11M-33.97M-56.60M-28.39M-25.72M-110.41M
Financing Cash Flow-30.06M-4.52M-13.04M-23.70M-6.21M-20.49M

HealthStream Technical Analysis

Technical Analysis Sentiment
Negative
Last Price22.04
Price Trends
50DMA
24.08
Negative
100DMA
25.78
Negative
200DMA
27.11
Negative
Market Momentum
MACD
-0.63
Positive
RSI
32.39
Neutral
STOCH
16.81
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HSTM, the sentiment is Negative. The current price of 22.04 is below the 20-day moving average (MA) of 23.08, below the 50-day MA of 24.08, and below the 200-day MA of 27.11, indicating a bearish trend. The MACD of -0.63 indicates Positive momentum. The RSI at 32.39 is Neutral, neither overbought nor oversold. The STOCH value of 16.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HSTM.

HealthStream Risk Analysis

HealthStream disclosed 38 risk factors in its most recent earnings report. HealthStream reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

HealthStream Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$1.17B8.5263.86%236.03%
69
Neutral
$650.62M32.145.87%0.52%3.68%5.62%
56
Neutral
$897.57M-33.6650.51%50.92%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
$163.39M-1.48-31.33%4.64%-17.17%
49
Neutral
$348.47M-1.45-47.69%-5.30%46.01%
48
Neutral
$435.24M-2.51-13.63%-16.65%-71.92%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HSTM
HealthStream
22.04
-9.79
-30.75%
EVH
Evolent Health
3.94
-6.22
-61.22%
HCAT
Health Catalyst
2.34
-3.16
-57.45%
NUTX
Clinigence Holdings
164.21
126.35
333.73%
DH
Definitive Healthcare Corp
2.43
-1.52
-38.48%
OMDA
Omada Health, Inc.
15.65
-6.95
-30.75%

HealthStream Corporate Events

M&A Transactions
HealthStream Acquires MissionCare Collective LLC
Positive
Dec 15, 2025

On December 15, 2025, HealthStream announced the acquisition of MissionCare Collective LLC, a healthcare workforce company known for its extensive caregiver network and flagship product, myCNAjobs.com. This acquisition marks the addition of HealthStream’s third Career Network, aimed at addressing the urgent need for non-medical caregivers, home health aides, and certified nurse assistants. The acquisition is expected to enhance HealthStream’s workforce ecosystem by offering comprehensive career tools and professional development opportunities, thereby creating synergies and adding value for stakeholders in the healthcare industry.

The most recent analyst rating on (HSTM) stock is a Hold with a $26.00 price target. To see the full list of analyst forecasts on HealthStream stock, see the HSTM Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
HealthStream CEO Donates Shares to Employees
Positive
Dec 9, 2025

On December 9, 2025, HealthStream‘s CEO, Robert A. Frist, Jr., contributed approximately $3.5 million of his personally owned shares to over 700 employees, excluding executives and vice presidents, as part of the company’s 2022 Omnibus Incentive Plan. This contribution, which includes an additional $275,000 to cover related company costs, will result in a compensation expense impacting the company’s financials in the fourth quarter of 2025, but it is seen as a positive move for employee engagement without affecting existing shareholders.

The most recent analyst rating on (HSTM) stock is a Hold with a $26.00 price target. To see the full list of analyst forecasts on HealthStream stock, see the HSTM Stock Forecast page.

Stock Buyback
HealthStream Announces $10 Million Share Buyback Program
Positive
Nov 12, 2025

On November 11, 2025, HealthStream announced that its Board of Directors approved a new share repurchase program, allowing the company to buy back up to $10 million of its outstanding common stock. This initiative, which is set to conclude by February 26, 2026, or when the maximum amount is spent, reflects HealthStream’s strategic financial management and could potentially enhance shareholder value, depending on market conditions and other factors.

The most recent analyst rating on (HSTM) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on HealthStream stock, see the HSTM Stock Forecast page.

DividendsFinancial DisclosuresM&A Transactions
HealthStream Reports Record Q3 Revenue and Acquisition
Positive
Nov 3, 2025

On November 3, 2025, HealthStream announced its third-quarter results, reporting a record revenue of $76.5 million, a 4.6% increase from the previous year. The company also declared a quarterly cash dividend and completed the acquisition of Virsys12, enhancing its provider data management capabilities. The acquisition is expected to strengthen HealthStream’s position in the healthcare technology market, particularly in provider network management.

The most recent analyst rating on (HSTM) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on HealthStream stock, see the HSTM Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025